Additional chemokines implicated in TLS development include CCL19 and CCL21, predominantly produced by DCs and HEV endothelial cells; their upregulation in tumor-associated TLS has prompted interest in their use as biomarkers and as targets for therapeutic interventions [13,31,35]. Here, CCL21 is linked to neoplasm.